CAS No 92943-93-6 MEGLUMINE GADOTERATE Pharmaceutical Intermediate

- Advanced Contrast Agent: MEGLUMINE GADOTERATE is a high performance gadolinium-based contrast agent for use in magnetic resonance imaging (MRI).
- Excellent safety: Designed with full consideration of patient safety, the incidence of adverse reactions is low.
- High Stability and Effectiveness: Provides excellent stability and effectiveness in improving MRI scan quality.
- Integrated Production and Trading: As an integrated production and trading factory, we ensure a seamless supply chain from manufacturing to delivery.
- Professionalism and Reliability: Our experienced team guarantees the highest quality and reliability for each batch of MEGLUMINE GADOTERATE.

product details

Product details

Product detail

Gadoterate meglumine, also known as gadoterate meglumine, is a gadolinium-based contrast agent with unique physical and chemical properties, making it an indispensable tool in the field of medical imaging. Its features include:

- Molecular formula: C23H42GdN5O13

- Molecular weight:753.86 g/mol

- Appearance: White to off-white solid.

- pH range: Typically between 6.0 and 7.5, compatible with physiological conditions

- Osmolarity: Lower osmolarity compared to other contrast agents, minimizing the risk of adverse reactions and improving patient comfort.

- Stability: MEGLUMINE GADOTERATE exhibits excellent stability under standard storage conditions, ensuring longer shelf life and reliability in clinical settings.

These physical and chemical properties enhance the compound's effectiveness as a contrast agent, enabling precise imaging and enhanced diagnostic capabilities.

product detail

CAS No.	40856-44-8
EINECS	609-874-3
Formula	C9H11NO2
Molecular Weight	165.19
Appearance	White to Off-White solid
Purity	≥98%
Type	Pharmaceutical Intermediates

Advantages

Meglumine plus docetaxel has numerous benefits that make it the preferred choice of healthcare professionals:

- Enhanced Imaging Quality: The compound significantly increases the contrast of MRI images, allowing for better visualization of anatomical structures and pathological conditions.

- Safety and Tolerability: MEGLUMINE GADOTERATE has a low incidence of adverse reactions and is well tolerated by patients, making it a safer option for enhanced imaging.

- Multiple Applications: Suitable for a wide range of imaging procedures, including brain, spine, and joint imaging, it is an indispensable tool in a variety of medical specialties.

- Rapid Clearance: Compounds are rapidly cleared from the body, reducing the risk of accumulation and associated side effects.

Commitment to Quality and Compliance

As a manufacturing and trading company, we prioritize quality and compliance in every aspect of our operations. Our commitment includes:

- State-of-the-art Manufacturing: Our factories are equipped with advanced technology and adhere to Good Manufacturing Practices (GMP), ensuring that every batch of MEGLUMINE GADOTERATE meets the highest quality standards.

- Strict Quality Control: Every production batch is thoroughly tested for purity, potency, and safety, ensuring our customers receive only the best products.

- TEAM OF EXPERTS: Our team of skilled professionals has years of experience in pharmaceutical manufacturing and trading, ensuring that we meet the diverse needs of our clients while maintaining the highest standards of quality and reliability.

In summary

In summary, meglumine plus doteric acid is an important contrast agent in the pharmaceutical industry, providing a reliable and effective solution for enhancing MRI imaging. With its unique physical and chemical properties, excellent safety profile, and our unwavering commitment to quality, this compound is expected to have a significant impact on diagnostic imaging. Partner with us to gain access to this innovative contrast agent and experience the benefits of working with a trusted integrated manufacturing and trading facility. Together, we can drive advancements in healthcare and improve patient outcomes around the world.